Ricardo P. Baptista

Ricardo Baptista has been working in Cell therapy Development globally, managing CMC teams on designing bioprocessing and analytical platforms for the scalable manufacture of allogeneic cell therapies in companies such as Procella Tx, Cellectis, CGT Catapult and CCRM. He was also involved in the generation and manufacture of clinical-grade iPSC lines, and in the design and construction of cleanroom facilities for CGT manufacturing according to GMP. Ricardo is a Biotechnology Engineer, who obtained his PhD degree in Biotechnology and Biochemical Engineering at Instituto Superior Tecnico, Portugal, and post-doctoral studies at Peter Zandstra’s Stem Cell Bioengineering Lab.